FDA Warns California Drugmaker for Testing Deficiencies, Missing Quality Unit

Drug Industry Daily
A A
The FDA issued a warning to bB Biochem Laboratories for unsupported product expiration dates, a failure to test incoming raw materials and for having no quality unit.

To View This Article:

Login

Subscribe To Drug Industry Daily